Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-01-04 @ 4:00 PM
Study NCT ID:
NCT05642468
Status:
COMPLETED
Last Update Posted:
2025-07-30
First Post:
2022-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
Sponsor:
Albireo, an Ipsen Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-10
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-23
First Submit QC Date:
None
Study First Post Date:
2022-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-29
Last Update Post Date:
2025-07-30
Last Update Post Date Type:
ACTUAL